Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) EV-to-Revenue : 0.49 (As of May. 26, 2024)

Aarey Drugs & Pharmaceuticals EV-to-Revenue Chart

Aarey Drugs & Pharmaceuticals Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
EV-to-Revenue		Get a 7-Day Free Trial					0.24	0.16	0.21	0.24	0.23

Aarey Drugs & Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															0.26	0.23	0.25	0.47	0.38

Competitive Comparison of Aarey Drugs & Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Aarey Drugs & Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aarey Drugs & Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarey Drugs & Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Aarey Drugs & Pharmaceuticals's EV-to-Revenue falls into.

Aarey Drugs & Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Aarey Drugs & Pharmaceuticals's EV-to-Revenue for today is calculated as:

Aarey Drugs & Pharmaceuticals's current Enterprise Value is ₹1,679 Mil.
Aarey Drugs & Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,420 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aarey Drugs & Pharmaceuticals  (NSE:AAREYDRUGS) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Aarey Drugs & Pharmaceuticals's PS Ratiofor today is calculated as:

Aarey Drugs & Pharmaceuticals's share price for today is ₹49.90.
Aarey Drugs & Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹134.74.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aarey Drugs & Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Aarey Drugs & Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Business Description